{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:48:03Z","timestamp":1788306483879,"version":"build-2803163510"},"reference-count":139,"publisher":"Baishideng Publishing Group Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2019,1,27]]},"DOI":"10.4254\/wjh.v11.i1.19","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T06:19:47Z","timestamp":1548569987000},"page":"19-36","source":"Crossref","is-referenced-by-count":38,"title":["Treatment of primary sclerosing cholangitis in children"],"prefix":"10.4254","volume":"11","author":[{"given":"Trevor J","family":"Laborda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Kyle","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Kavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Deneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26454"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29204"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.09.010"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14540"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Smit JJ, Schinkel AH, Oude Elferink RP, Groen AK, Wagenaar E, van Deemter L, Mol CA, Ottenhoff R, van der Lugt NM, van Roon MA. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75: 451-462","DOI":"10.1016\/0092-8674(93)90380-9"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24691"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.05.009"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2016.09.004"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Galle PR, Theilmann L, Raedsch R, Otto G, Stiehl A. Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology 1990; 12: 486-491","DOI":"10.1002\/hep.1840120307"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Stiehl A, Rudolph G, Raedsch R, M\u00f6ller B, Hopf U, Lotterer E, Bircher J, F\u00f6lsch U, Klaus J, Endele R. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology 1990; 12: 492-497","DOI":"10.1002\/hep.1840120308"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Calmus Y, Gane P, Rouger P, Poupon R. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1990; 11: 12-15","DOI":"10.1002\/hep.1840110104"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Harrison JM, Wiesner RH, Anderson ML, Lange SM. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106: 1284-1290","DOI":"10.1016\/0016-5085(94)90021-3"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 1996; 110: 1515-1518","DOI":"10.1053\/gast.1996.v110.pm8613058"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703063361003"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.12.023"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.08.017"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03777.x"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23082"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283554bbf"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23294"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29882"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27074"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27180"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1251"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.12.032"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.10.013"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12979"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13110"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2010.12.008"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04863.x"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Gilger MA, Gann ME, Opekun AR, Gleason WA Jr. Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children. J Pediatr Gastroenterol Nutr 2000; 31: 136-141","DOI":"10.1097\/00005176-200008000-00009"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Black D MC, Kerkar N, Miloh T, Sundaram S, Anand R, Gupta A, Alonso E, Arnon R, Bulut P, Karpen S, Lin C, Rosenthal P, Ryan M, Squires R, Valentino P, Schneider B. Initial Results of the WUPPSC Study - Prospective Multicenter Withdrawal of Ursodeoxycholic Acid in Pediatric Primary Sclerosing Cholangitis. Gastroenterology 2018; 154: S1209","DOI":"10.1016\/S0016-5085(18)33994-5"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Lichtman SN, Sartor RB, Keku J, Schwab JH. Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology 1990; 98: 414-423","DOI":"10.1016\/0016-5085(90)90833-M"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju023"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.24231"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv204"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310500"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311004"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23870-w"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000102"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Mistilis SP, Skyring AP, Goulston SJ. Effect of long-term tetracycline therapy, steroid therapy and colectomy in pericholangitis associated with ulcerative colitis. Australas Ann Med 1965; 14: 286-294","DOI":"10.1111\/imj.1965.14.4.286"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.14"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20457"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12232"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31816fee95"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1086\/491708"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9801-1"},{"key":"ref48","unstructured":"Deneau MR, Amin M, Amir AZ, Auth M, Bazerbachi F, Broderick A, El-Youssef M, Ferrari F, Furuya KN, Gottrand F, Gupta N, Homan M, Kamath BM, Lin H, Mo Kim K, Kolho KL, Konidari A, Koot B, Iorio R, Jensen MK, Mack C, Martinez M, Ricciuto A, Smolka V, Tanaka A, Valentino PL, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Miloh T. Variability in Diagnostic and Therapeutic Strategies for Pediatric Primary Sclerosing Cholangitis between Centers in the Pediatric PSC Consortium. Hepatology 2018; 68"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.15403\/jgld.2014.1121.254.rah"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001368"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.07.022"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3745"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2616"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.03.031"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14829"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Bj\u00f6rnsson E, Cederborg A, Akvist A, Simren M, Stotzer PO, Bjarnason I. Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2005; 40: 1090-1094","DOI":"10.1080\/00365520510023288"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i29.5412"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Lichtman SN, Keku J, Schwab JH, Sartor RB. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 1991; 100: 513-519","DOI":"10.1016\/0016-5085(91)90224-9"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07374-9"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13092"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27085"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Sokol H, Cosnes J, Chazouilleres O, Beaugerie L, Tiret E, Poupon R, Seksik P. Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World J Gastroenterol 2008; 14: 3497-3503","DOI":"10.3748\/wjg.14.3497"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00947.x"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001531"},{"key":"ref65","unstructured":"Stockbr\u00fcgger RW, Olsson R, Jaup B, Jensen J. Forty-six patients with primary sclerosing cholangitis: radiological bile duct changes in relationship to clinical course and concomitant inflammatory bowel disease. Hepatogastroenterology 1988; 35: 289-294"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14393"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.55"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i6.1956"},{"key":"ref69","unstructured":"Mosli M, Croome K, Qumosani K, Al-Judaibi B, Beaton M, Marotta P, Chandok N. The effect of liver transplantation for primary sclerosing cholangitis on disease activity in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2013; 9: 434-441"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izx096"},{"key":"ref71","unstructured":"Lindor KD, Wiesner RH, Colwell LJ, Steiner B, Beaver S, LaRusso NF. The combination of prednisone and colchicine in patients with primary sclerosing cholangitis. Am J Gastroenterol 1991; 86: 57-61"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02267.x"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02323.x"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Knox TA, Kaplan MM. A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 1994; 106: 494-499","DOI":"10.1016\/0016-5085(94)90610-6"},{"key":"ref75","unstructured":"Lindor KD, Jorgensen RA, Anderson ML, Gores GJ, Hofmann AF, LaRusso NF. Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study. Am J Gastroenterol 1996; 91: 511-515"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02214.x"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.40484.x"},{"key":"ref78","unstructured":"Van Thiel DH, Carroll P, Abu-Elmagd K, Rodriguez-Rilo H, Irish W, McMichael J, Starzl TE. Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. Am J Gastroenterol 1995; 90: 455-459"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181662426"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Epstein MP, Kaplan MM. A pilot study of etanercept in the treatment of primary sclerosing cholangitis. Dig Dis Sci 2004; 49: 1-4","DOI":"10.1023\/B:DDAS.0000011827.87103.2e"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000596"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy065"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22131"},{"key":"ref84","unstructured":"Pallavicino F, Pellicano R, Reggiani S, Simondi D, Sguazzini C, Bonagura AG, Cisar\u00f2 F, Rizzetto M, Astegiano M. Inflammatory bowel diseases and primary sclerosing cholangitis: hepatic and pancreatic side effects due to azathioprine. Eur Rev Med Pharmacol Sci 2013; 17: 84-87"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000847"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.01.020"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Broom\u00e9 U, L\u00f6fberg R, Lundqvist K, Veress B. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis Colon Rectum 1995; 38: 1301-1305","DOI":"10.1007\/BF02049156"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Lazaridis KN, LaRusso NF. Primary Sclerosing Cholangitis. N Engl J Med 2016; 375: 2501-2502","DOI":"10.1056\/NEJMra1506330"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-111203"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29726"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27973"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000591"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29477"},{"key":"ref94","unstructured":"Yu DC, Mennone A, Vig P, Boyer J. Cenicriviroc, a cytokine receptor antagonist, potentiated the effects of all-trans retinoic acid by reducing neutrophils and T cells in the liver of rodent cholestatic models. Hepatology 2017; 66: 938-939"},{"key":"ref95","unstructured":"Waye JD. Endoscopic retrograde cholangiopancreatography in the infant. Am J Gastroenterol 1976; 65: 461-463"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31817a24cf"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2017.01.051"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-017-0959-9"},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"Bonasso PC, Gurien LA, Staszak J, Gowen ME, Troendle DM, Odiase E, Lazar L, Ruan W, Barth BA, Williams RF, Dassinger MS. In-Hospital Pediatric ERCP is Associated with Shorter Hospitalization for Children with Choledocholithiasis. J Pediatr Gastroenterol Nutr 2018;","DOI":"10.1097\/MPG.0000000000002102"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000000124"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.112"},{"key":"ref102","doi-asserted-by":"crossref","unstructured":"Stiehl A, Rudolph G, Kl\u00f6ters-Plachky P, Sauer P, Walker S. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol 2002; 36: 151-156","DOI":"10.1016\/S0168-8278(01)00251-3"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03690.x"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-107029"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.05.034"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3152-0"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13817"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.5274"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.7521"},{"key":"ref110","unstructured":"Jones EA, Molenaar HA, Oosting J. Ondansetron and pruritus in chronic liver disease: a controlled study. Hepatogastroenterology 2007; 54: 1196-1199"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05852.x"},{"key":"ref112","unstructured":"Bolier AR, Peri S, Oude Elferink RP, Beuers U. The challenge of cholestatic pruritus. Acta Gastroenterol Belg 2012; 75: 399-404"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.287"},{"key":"ref114","doi-asserted-by":"crossref","unstructured":"Corpechot C, Chazouilleres O, Rousseau A. A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate response to ursodeoxycholic acid therapy. Hepatology 2017; 66","DOI":"10.1016\/S0168-8278(17)30442-7"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28256"},{"key":"ref116","unstructured":"Laboratories MM. Alkaline Phosphatase, Total and Isozymes, Serum: Clinical and Interpretive. Hepatology 2017; 64: 256-258"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.v3i1.02"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.4137\/CMPed.S6872"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27825"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-018-4083-2"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22396"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001438"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22320"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31821694b3"},{"key":"ref125","unstructured":"Deneau MR, Amin M, Amir AZ, Auth M, Bazerbachi F, Broderick A, El-Youssef M, Ferrari F, Furuya KN, Gottrand F, Gupta N, Homan M, Kamath BM, Lin H, Mo Kim K, Kolho KL, Konidari A, Koot B, Iorio R, Jensen MK, Mack C, Martinez M, Ricciuto A, Smolka V, Tanaka A, Valentino PL, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Miloh T. MELD score and liver transplantation in children with primary sclerosing cholangitis. Pediatric Gastroenterology Nutrition 2018; 67"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-014-1237-z"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.04.008"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.12.027"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01333.x"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i28.3171"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27307"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2013.01.066"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-016-0192-3"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13894"},{"key":"ref135","doi-asserted-by":"crossref","unstructured":"Deneau MR, El-Matary W, Valentino PL, Abdou R, Alqoaer K, Amin M, Amir AZ, Auth M, Bazerbachi F, Broderick A, Chan A, Cotter J, Doan S, El-Youssef M, Ferrari F, Furuya KN, Gottrand M, Gottrand F, Gupta N, Homan M, Kamath BM, Mo Kim K, Kolho KL, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, O'Cathain N, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Jensen MK. Recurrence of primary sclerosing cholangitis after liver transplantation in children: data from the Pediatric PSC Consortium. Hepatology 2017; 66: S76","DOI":"10.1016\/S0168-8278(17)30414-2"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-018-0649-2"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000760"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1002\/lt.23741"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.02.014"}],"container-title":["World Journal of Hepatology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v11\/i1\/19.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T11:20:21Z","timestamp":1573816821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v11\/i1\/19.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,27]]},"references-count":139,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,27]]}},"URL":"https:\/\/doi.org\/10.4254\/wjh.v11.i1.19","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,27]]}}}